Edition:
Deutschland

Restorbio Inc (TORC.OQ)

TORC.OQ on NASDAQ Stock Exchange Global Select Market

1.23USD
13 Dec 2019
Change (% chg)

$-0.01 (-0.81%)
Prev Close
$1.24
Open
$1.24
Day's High
$1.25
Day's Low
$1.22
Volume
148,114
Avg. Vol
156,245
52-wk High
$13.50
52-wk Low
$0.94

About

resTORbio, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of novel therapeutics for the treatment of aging-related diseases. It focuses on the mechanistic target of rapamycin (mTOR) pathway that regulates aging, and specifically on selective inhibition of the... (more)

Buy/Sell

Sell Hold Buy
3.17 Mean rating from 6 analysts

Overall

Beta: --
Market Cap(Mil.): $44.83
Shares Outstanding(Mil.): 36.44
Dividend: --
Yield (%): --

ResTORbio's respiratory illness drug fails late-stage study

Nov 15 ResTORbio Inc's said on Friday its lead drug missed the main goal in a late-stage testing in patients aged above 65 with respiratory illness.

Märkte

  • U.S.
  • Europa
  • Asien
  • Branchen

Branchenüberblick

Energie +0.24%
Rohstoffe +0.50%
Industrie +0.54%
Konjunktur abhängige Waren & Dienstleistungen +0.62%
Konjunktur unabhängige Waren & Dienstleistungen +0.21%
Finanzindustrie +0.15%
Pharma +0.50%
Technologie -0.02%
Telekommunikation +1.13%

Nachrichten aus der Wirtschaft